Nexium Dyspepsia/AST

Study identifier:SD-NED-0022

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Supportive Test for Acid-Related Symptoms (STARS II) with esomeprazole and a following 7-week, double-blind, randomized, placebo controlled treatment period in uninvestigated subjects with upper gastrointestinal symptoms.

Medical condition

Gastrointestinal disease

Phase

Phase 3

Healthy volunteers

Study drug

Esomeprazole

Sex

All

Actual Enrollment

1200

Study type

Interventional

Age

18 Years - 50 Years

Date

Study Start Date: 01 Dec 2002

Primary Completion Date: 01 Jan 2005

Study Completion Date: 01 Jan 2005

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

CSR-SD-NED-0022.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information

[email protected]

Investigators

Principal Investigator

AstraZeneca Nexium Medical Sciences Director

AstraZeneca